I n this edition of The Canadian Journal of Psychiatry,
Dr Marilyn A Craven and Dr Roger Bland 1 cite studies suggesting that around 10% of primary care patients are likely to meet diagnostic criteria for MDD, and that numbers will rise as the baby boomer cohort ages and the prevalence of chronic physical disease increases. They suggest that the persistently low rates of detection, treatment, and follow-up found in primary care need addressing to improve treatment adherence and patient outcomes, and that newer evidencebased models of case management and collaborative care need to be adopted, integrating care for depression with that for physical diseases. 1 Alongside this very useful overview of the issues, Dr Linda Gask 2 reviews studies of educating FPs about the identification and treatment of depression, and points out that simple education has largely failed to change practice. She identifies perceived structural obstacles to change, including a relative lack of time and resources in primary care, but highlights a tendency among FPs to conceptualize depression as reactive or endogenous, with subsequent uncertainty about treating it in the face of adverse life events and difficulties. 2 This implies that FPs perceive limits to the medical model of depression inherent in the research described by Dr Craven and Dr Bland, 1 and the need to take social factors into account, but that they are uncertain about how to do so in practice.
We know that the onset of depression is often provoked by adverse social circumstances, 3, 4 and that the prevalence of depression differs markedly between populations, in accordance with rates of social adversity. 5 Cross-sectional surveys using consistent diagnostic criteria suggest that the prevalence of MDD doubled among US adults between 1992 and 2002, 6 and all high-income countries saw yearon-year increases in AD prescribing in primary care in the 1990s following the introduction of the selective serotonin reuptake inhibitors, 7 prompting talk of a depression epidemic, although we found increased AD prescribing in the United Kingdom to be due to increases in the proportion of sufferers being put on long-term treatment, rather than to a rise in the incidence of depression. 7 Rates of consulting for depression actually seemed to be falling during the period of relative affluence in the United Kingdom from 2000 onwards, 7, 8 at least up until the economic crash in 2008. 8 FPs may well question the extent to which they can ameliorate the effects of changes in their patients' financial security, employment, and housing. Anderson et al 9 pointed out 20 years ago that the prevalence of case-level psychological distress in a population correlates highly with the mean population level of psychological distress, indicating for them that
The mental health of society is integral and reflects its social economic and political structure. At this point psychiatric epidemiology and prevention merge into social policy-they cannot exist apart. 9, p 484 Therefore, interventions are most likely to be effective if they affect the whole of the population rather than the highrisk tail. However, despite this, professionals faced with people in distress must do the best they can for them, even if political solutions may seem to be more likely to make a difference at the population level.
The extent to which the recognition of depression by FPs needs to be improved has been questioned, and the old notion that FPs miss 50% or more of cases may be doing them a disservice. Studies have suggested that missed cases tend to be milder, 10, 11 and that the recognition of moderateto-severe depression, where the evidence of benefit from treatment is stronger, is actually quite good. 11 In the World Health Organization naturalistic study, in 15 cities around the world, patients whose depression went unrecognized had milder depression at baseline and were not found to have worse outcomes than those recognized. 12 Kessler et al's 13 longitudinal study in UK general practice found that many patients with depression who were not diagnosed at a single consultation were diagnosed at subsequent consultations, or recovered without a diagnosis. Conversely, 3 years later, 14% of patients with depression still had a clinically severe condition, had not received a diagnosis, and may have benefited from treatment, 13 thus we cannot be complacent about the recognition of depression in primary care. Dr Craven and Dr Bland 1 cite a recent metaanalysis 14 suggesting that diagnosis could be improved by the reassessment of people who may have depression.
Dr Craven and Dr Bland 1 also suggest research needs to address why FPs frequently do not initiate treatment even when MDD is detected. We found that FPs did not always acknowledge perceived depression among patients who were consulting them for other reasons, 15 implying they do not think it always helpful to do so. It may be because they are unsure whether AD treatment is helpful in the face of social adversity or a lack of social support. National guidelines for depression around the world are largely silent on this issue. 16 In a pragmatic trial of ADs for mild-to-moderate depression in primary care, we found that remission rates among patients in aversive social contexts were consistently much lower, irrespective of treatment. 17 However, current guidance is that depression of sufficient severity should be treated with ADs regardless of the presence of adverse life events. 18 There is a need for more prospective research into the influence of social factors on the effectiveness of treatment with ADs, as well as into the effectiveness of social interventions for depression in primary care, such as befriending, increasing social networks, improving parenting skills, and tackling domestic violence.
We do know that the benefit of AD treatment, compared with placebo, is greater the greater the severity of depression, 19 but that FPs are not good at determining severity, compared with standardized measures of severity. 10, 15 Financial incentives were introduced in the UK general practice contract QOF to encourage FPs to measure symptom severity with standardized questionnaires as an attempt to help inform treatment decisions. However, our subsequent qualitative research suggested that such questionnaires were unpopular with many FPs who considered their clinical judgement to be more important and were concerned that the assessments reduced the human element of the consultation. 20 Our analysis of medical record data indicated that treatment decisions were not based on questionnaire scores alone but that FPs also took into account other factors, such as age and physical illness. Rates of treatment were lower for older patients and for patients with comorbid physical illness, including coronary heart disease and diabetes, despite the QOF encouraging screening for depression among such patients. 21 FPs may have been concerned about the side effects of ADs affecting the comorbid physical problems, but referral for psychological treatments was also less likely among older patients. 21 Patients with comorbid physical conditions and multiple medications may be reluctant to accept either treatment or referral, especially if their psychological problem has been detected by screening rather than presenting symptoms themselves. The acceptability of treatment in such circumstances is another area that needs researching, given the likely future continued rise in the prevalence of depression associated with physical diseases in older patients.
The treatment of MDD has been shown to be much improved through case management, which is active follow-up by a dedicated professional who reinforces the need to continue treatment, and by collaborative care, where access to psychiatric and psychological treatment is increased through primary-secondary care collaboration. 22, 23 However, such care is more expensive and has not been rolled out to everyday practice, even in the United States, where most of the research showing its effectiveness has been carried out.
Arguments for an expansion of psychological services in the United Kingdom have succeeded as they may pay for themselves if they allow patients to stop using health services, get back to work, and come off benefits. 24 The UK's IAPT program 25 represents the biggest central funding commitment to psychological therapies in the history of the National Health Service, and its first systematic attempt to respond to the chronic underprovision of services in the psychological therapies field. Our evaluation of the IAPT demonstration sites showed that such services could significantly increase access to psychological treatments for people with common mental health problems, including depression. 26 However, although referral for psychological treatment was associated with reduced sickness absence and use of health care, only a small minority (6%) of patients diagnosed were referred to the IAPT services, even with this markedly increased investment. 27 As Shepherd et al 28 pointed out nearly 50 years ago, depression is too common for specialist services to be provided to all diagnosed patients. Therefore, the large majority of people with depression will continue to be managed entirely in primary care, if they are managed at all. More research needs to be done into innovative nondrug treatment strategies, based at least partly on self-help, administered by new methods, including mobile devices and the Internet, and supported by nonspecialist practitioners. 29 However, ultimately, social changes are likely to be essential to increase people's support for each other and reverse some of the trends toward the fragmentation of society in the 21st century.
